Daiwa Securities Group Inc. Acquires 3,003,845 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

Daiwa Securities Group Inc. increased its holdings in Omega Healthcare Investors, Inc. (NYSE:OHI) by 317.7% during the third quarter, Holdings Channel.com reports. The firm owned 3,949,368 shares of the real estate investment trust’s stock after acquiring an additional 3,003,845 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Omega Healthcare Investors were worth $160,739,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the business. Charles Schwab Investment Management Inc. increased its holdings in shares of Omega Healthcare Investors by 6.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 3,830,302 shares of the real estate investment trust’s stock worth $155,893,000 after buying an additional 240,006 shares during the period. Dimensional Fund Advisors LP lifted its position in Omega Healthcare Investors by 7.9% in the second quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock valued at $127,831,000 after purchasing an additional 272,299 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Omega Healthcare Investors by 4.6% during the second quarter. Bank of New York Mellon Corp now owns 3,240,025 shares of the real estate investment trust’s stock valued at $110,971,000 after purchasing an additional 143,521 shares during the period. LSV Asset Management grew its holdings in shares of Omega Healthcare Investors by 0.7% in the second quarter. LSV Asset Management now owns 1,968,200 shares of the real estate investment trust’s stock worth $67,411,000 after purchasing an additional 14,000 shares during the last quarter. Finally, Assetmark Inc. increased its stake in shares of Omega Healthcare Investors by 1.7% in the third quarter. Assetmark Inc. now owns 1,191,460 shares of the real estate investment trust’s stock worth $48,492,000 after buying an additional 19,542 shares during the period. 65.25% of the stock is owned by institutional investors.

Omega Healthcare Investors Trading Down 0.1 %

NYSE OHI opened at $40.11 on Friday. Omega Healthcare Investors, Inc. has a 12 month low of $27.53 and a 12 month high of $44.42. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10. The stock’s fifty day moving average price is $40.62 and its 200-day moving average price is $37.01. The stock has a market cap of $10.83 billion, a P/E ratio of 29.49, a P/E/G ratio of 1.25 and a beta of 0.99.

Omega Healthcare Investors Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were issued a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.68%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors’s payout ratio is 197.06%.

Insider Activity at Omega Healthcare Investors

In other news, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the transaction, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. The trade was a 36.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at $7,357,824.44. This trade represents a 10.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

OHI has been the subject of several analyst reports. BMO Capital Markets increased their price target on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research report on Monday, October 7th. Scotiabank lifted their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research report on Monday, August 26th. BNP Paribas raised shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price objective on the stock in a research report on Thursday, October 31st. Royal Bank of Canada boosted their price target on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a research report on Monday, November 11th. Finally, Wells Fargo & Company restated an “overweight” rating and issued a $43.00 target price (up previously from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Seven equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $40.00.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.